Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Characterizing the Eaf complex using HDX-MS

ABSTRACT: Map the key residues and interaction surface between Eaf3 and Eaf5/7 using HDX-MS

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: John Burke

LAB HEAD: Dr. John E Burke

PROVIDER: PXD025715 | Pride | 2022-09-21

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	08_10_2020_KFHDX13_Eaf357_ND_0_01_14947.d.zip	Other
	08_10_2020_KFHDX13_Eaf3_3s_1_0_01_14949.d.zip	Other
	08_10_2020_KFHDX13_Eaf3_ND_0_01_14943.d.zip	Other
	09_10_20_KFHDX13_357_3s_1_0_01_14955.d.zip	Other
	09_10_20_KFHDX13_Eaf3_30s_1_0_01_14959.d.zip	Other

Items per page:

1 - 5 of 77

Similar Datasets

HDX-MS Analysis of the PI4K EFR3A Complex

Project description:HDX-MS analysis examining the complex that forms between the subunits of PI4KIIIa and EFR3A

2025-03-10 | PXD043442 | Pride

Structure of the phosphoinositide 3-kinase p110-p101 complex reveals molecular mechanism of GPCR activation

Project description:The class IB phosphoinositide 3-kinase (PI3K), PI3K, is a master regulator of immune cell function, and is a promising drug target for both inflammatory diseases and cancer. Critical to PI3K function is the association of the p110 catalytic subunit to either a p101 or p84 regulatory subunit, which mediates regulation by G-protein coupled receptors (GPCRs). Here, we report the first structure of a heterodimeric PI3K complex, p110-p101. This structure revealed a unique mode of assembly of catalytic and regulatory subunits distinct from that of other class I PI3K complexes. Multiple oncogenic mutations mapped to these novel interfaces led to increased activation by G. p101 mediates activation through its G binding domain, recruiting the complex to the membrane and allowing for engagement of a secondary site in p110. A nanobody that specifically binds to this p101-G interface blocks activation providing a novel tool to study p101-specific signaling events in vivo.

2021-09-22 | PXD025209 | Pride

Defining the molecular mechanism of PI4KA complex regulation by the phosphatase Calcineurin

Project description:To examine the interaction between PI4KIIIa and Calcineurin, HDX-MS experiments comparing calcineurin or PI4KA FAM delta C alone to the calcineurin and PI4KA FAM delta C complex were carried out.

2024-09-03 | PXD043409 | Pride

ATP-competitive and allosteric inhibitors induce differential conformational changes at the autoinhibitory interface of Akt

Project description:We use HDX-MS to interrogate the AKT1 DrLink conformational changes upon binding AKT1 active site inhibitors A-443654, Capivasertib, and Uprosertib, Akt1 allosteric inhibitor MK-2206, and ADP.

2024-08-23 | PXD039028 | Pride

Hydrogen Deuterium Exchange of PDK1

Project description:This project consisted of three HDX-MS experiments. First, we compared the dimeric PDK1(SKD-PIF) to monomeric PDK1(SKD) and mapped the differences in deuterium incorporation onto the dimer model. We then compared the deuterium incorporation kinetics for the kinase (PDK1(SKD)) and PH (PDK1(PH) domains of PDK1 with full-length PDK1 (PDK1(FL)) in pairwise experiments.

2022-05-20 | PXD027401 | Pride

Study of the TRAPP complexes by HDX-MS

Project description:Use of HDX-MS to study the allosteric and structural differences between the TRAPPII and TRAPPIII complex in the presence and absence of membrane and rab GTPases

2021-09-22 | PXD025928 | Pride

HDX-MS analysis of the mechanism of AKT1 inhibitor binding

Project description:Analysis of AKT1 inhibitor binding using HDX-MS .

2023-02-22 | PXD032929 | Pride

HDX-MS Analysis of CeSpartin and CtSpartinL

Project description:HDX-MS analysis of SPG20, determining the seconday structure of CeSpartin and comparing WT CtSpartinL and A290P CtSpartinL.

2023-12-27 | PXD043175 | Pride

HDX-MS analysis of a TTC7B specific nanobody to inhibit EFR3 mediated PI4KA recruitment

Project description:Phosphatidylinositol 4 kinase III (PI4KIII/PI4KA) is an essential lipid kinase that is critical for regulating plasma membrane identity. PI4KA is primarily recruited to the plasma membrane through targeted recruitment by the proteins EFR3A and EFR3B, with these binding to the PI4KA accessory proteins TTC7 (TTC7A and TTC7B) and FAM126 (FAM126A and FAM126B). Here we characterised how both EFR3 isoforms interact with all possible TTC7 and FAM126 combinations and developed a nanobody that specifically blocks EFR3 mediated PI4KA recruitment in TTC7B containing complexes. Using a yeast display approach, we generated a nanobody that is selective for TTC7B and blocks EFR3 binding. Cryo-electron microscopy and hydrogen deuterium exchange mass spectrometry reveal that the nanobody sterically blocks EFR3 recruitment and shows an extended interface with both PI4KA and TTC7B. Overall, this work provides insight into PI4KA regulation and is a useful tool for manipulating unique complexes of PI4KA that may be valuable for future therapeutic targeting of PI4KA.

2025-11-20 | PXD066213 | Pride

Characterization of m-lipin using HDX-MS

Project description:This project consists of two experiments. The first is mapping the binding interface between the isolated m-lip domain of mouse lipin and liposomes. The second experiments is mapping the binding interface between full length mouse lipin and liposomes. Looking at the isolated m-lip domain, we found that residues 470-490 and 500-550 showed decreases in exchange upon liposome binding. The full-length lipin experiment saw decreases in exchnage in these same regions, as well as in the very C-terminus and very N-terminus regions of the protein. An order-disorder experiment was done on full length lipin where the protein was exposed to a short pulse of deuterium and compared to the fully-deuterated protein. In this instance, we established that the majority of the protein is relatively disordered and does not have secondary structure with high stability

2021-06-29 | PXD022172 | Pride